Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Int J Cancer ; 132(7): 1613-23, 2013 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-22965462

RESUMEN

Noninvasive localized measurement of extracellular pH in cancer tissues can have a significant impact on the management of cancer. Despite its significance, there are limited approaches for rapid and noninvasive measurement of local pH in a clinical environment. In this study, we demonstrate the potential of noninvasive topical delivery of Alexa-647 labeled pHLIP (pH responsive peptide conjugated with Alexa Fluor(®) 647) to image changes in extracellular pH associated with head and neck squamous cell carcinoma using widefield and high resolution imaging. We report a series of preclinical analyses to evaluate the optical contrast achieved after topical delivery of Alexa-647 labeled pHLIP in intact fresh human tissue specimens using widefield and high-resolution fluorescence imaging. Using topical delivery, Alexa-647 labeled pHLIP can be rapidly delivered throughout the epithelium of intact tissues with a depth exceeding 700 µm. Following labeling with Alexa-647 labeled pHLIP, the mean fluorescent contrast increased four to eight fold higher in clinically abnormal tissues as compared to paired clinically normal biopsies. Furthermore, the imaging approach showed significant differences in fluorescence contrast between the cancer and the normal biopsies across diverse patients and different anatomical sites (unpaired comparison). The fluorescence contrast differences between clinically abnormal and normal tissues were in agreement with the pathologic evaluation. Topical application of fluorescently labeled pHLIP can detect and differentiate normal from cancerous tissues using both widefield and high resolution imaging. This technology will provide an effective tool to assess tumor margins during surgery and improve detection and prognosis of head and neck cancer.


Asunto(s)
Carcinoma in Situ/patología , Neoplasias de Cabeza y Cuello/patología , Proteínas de la Membrana/metabolismo , Imagen Molecular , Imagen Óptica , Anciano , Anciano de 80 o más Años , Carcinoma in Situ/metabolismo , Femenino , Neoplasias de Cabeza y Cuello/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Masculino , Microscopía Fluorescente , Persona de Mediana Edad , Invasividad Neoplásica , Pronóstico , Succinimidas
2.
JAMA Facial Plast Surg ; 16(6): 437-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25211530

RESUMEN

IMPORTANCE: Classically, pterygoid plate fractures have been associated with fractures of the mid-face and skull base. When isolated pterygoid plate fractures are identified on imaging that only extends to the level of the skull base, other related facial fractures may be missed. We sought to evaluate isolated lateral pterygoid plate fractures on computed tomography (CT) scans in conjunction with mandible fractures and to propose a mechanism of fracture unrelated to the classic dissociating mid-face Le Fort fractures. OBSERVATIONS: In this retrospective case series, 7 patients who sustained facial trauma from 2006 to 2012 were found to have isolated lateral pterygoid plate fractures. All patients had an ipsilateral subcondylar fracture, 2 had symphyseal fracture, 2 had body fracture, and 1 had coronoid fracture. CONCLUSIONS AND RELEVANCE: On the basis of these cases, isolated lateral pterygoid fractures noted on CT of the head may be suggestive of an unappreciated mandibular fracture. The suspected mechanism is due to force transduction through the medial and lateral pterygoid muscles when acute displacing force is placed on the mandible. In patients with identified isolated pterygoid plate factures, a dedicated CT of the mandible may be indicated to assess for associated mandibular fracture, even in patients whose clinical examinations have had negative results.


Asunto(s)
Fracturas Mandibulares/diagnóstico por imagen , Fosa Pterigopalatina/diagnóstico por imagen , Fosa Pterigopalatina/lesiones , Fracturas Craneales/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Adulto , Humanos , Masculino , Fracturas Mandibulares/cirugía , Persona de Mediana Edad , Fosa Pterigopalatina/cirugía , Fracturas Craneales/cirugía , Adulto Joven
3.
Cancer Prev Res (Phila) ; 7(10): 1035-44, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25139295

RESUMEN

The overall objective of this study was to develop an optical imaging approach to simultaneously measure altered cell metabolism and changes in tissue extracellular pH with the progression of cancer using clinically isolated biopsies. In this study, 19 pairs of clinically normal and abnormal biopsies were obtained from consenting patients with head and neck cancer at University of California, Davis Medical Center. Fluorescence intensity of tissue biopsies before and after topical delivery of 2-NBDG (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose) and Alexa 647-pHLIP [pH (low) insertion peptide] was measured noninvasively by widefield imaging, and correlated with pathologic diagnosis. The results of widefield imaging of clinical biopsies demonstrated that 2-NBDG and pHLIP peptide can accurately distinguish the pathologically normal and abnormal biopsies. The results also demonstrated the potential of this approach to detect subepithelial lesions. Topical application of the contrast agents generated a significant increase in fluorescence contrast (3- to 4-fold) in the cancer biopsies as compared with the normal biopsies, irrespective of the patient and location of the biopsy within a head and neck cavity. This unpaired comparison across all the patients with cancer in this study highlights the specificity of the imaging approach. Furthermore, the results of this study indicated that changes in intracellular glucose metabolism and cancer acidosis are initiated in the early stages of cancer, and these changes are correlated with the progression of the disease. In conclusion, this novel optical molecular imaging approach to measure multiple biomarkers in cancer has a significant potential to be a useful tool for improving early detection and prognostic evaluation of oral neoplasia.


Asunto(s)
Glucosa/farmacocinética , Neoplasias de Cabeza y Cuello/diagnóstico , Neoplasias de Cabeza y Cuello/metabolismo , Neoplasias de la Boca/diagnóstico , 4-Cloro-7-nitrobenzofurazano/análogos & derivados , Acidosis/metabolismo , Acidosis/patología , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/metabolismo , Biopsia , Carbocianinas , Medios de Contraste/farmacocinética , Desoxiglucosa/análogos & derivados , Progresión de la Enfermedad , Femenino , Humanos , Concentración de Iones de Hidrógeno , Masculino , Microscopía Fluorescente , Persona de Mediana Edad , Neoplasias de la Boca/patología , Imagen Óptica , Óptica y Fotónica , Pronóstico
4.
Curr Opin Otolaryngol Head Neck Surg ; 21(5): 492-6, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23995329

RESUMEN

PURPOSE OF REVIEW: This review will consider the newly developed and emerging diagnostic techniques with real or potential clinical application to the diagnosis of Ménière's disease. RECENT FINDINGS: Several new diagnostic modalities have been introduced, which have the potential to help diagnose endolymphatic hydrops. These include cervical and ocular vestibular evoked myogenic potentials, cochlear hydrops analysis masking procedures, and three-dimensional fluid-attenuated inversion recovery MRI following intratympanic instillation of gadolinium. SUMMARY: Diagnosis of Ménière's disease has classically been of a clinical rather than a procedural nature. Despite the many recent advances in diagnostic testing which show potential applicability for aiding in diagnosis of Ménière's disease, each has limitations which prevent immediate utility. For now, Ménière's disease remains best diagnosed through the standard American Academy of Otolaryngology - Head and Neck Surgery clinical inclusionary and exclusionary criteria.


Asunto(s)
Enfermedad de Meniere/diagnóstico , Electronistagmografía , Hidropesía Endolinfática/diagnóstico , Potenciales Evocados Auditivos del Tronco Encefálico , Gadolinio/administración & dosificación , Humanos , Instilación de Medicamentos , Imagen por Resonancia Magnética/métodos , Enfermedad de Meniere/fisiopatología , Membrana Timpánica , Potenciales Vestibulares Miogénicos Evocados
5.
Cardiovasc Pathol ; 18(2): 77-82, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-18402839

RESUMEN

INTRODUCTION: Osteopontin (OPN) is a potent inhibitor of ectopic calcification. Previous studies suggested that, in addition to blocking apatite crystal growth, OPN promoted regression of ectopic calcification by inducing the expression of acid-generating carbonic anhydrase II (CAR2) in monocyte-derived cells. METHODS: To test this hypothesis, OPN and CAR2 expression and calcification of subcutaneously implanted glutaraldehyde-fixed bovine pericardium (GFBP) were studied in CAR2 mutant mice. RESULTS: Consistent with previous studies in Black Swiss mice, GFBP calcified to a greater extent in OPN-deficient mice compared to wild types on the C57Bl/6 background. GFBP implanted in CAR2-deficient mice (CAR2(-/-)) were significantly more calcified than those implanted into wild-type mice (CAR2(+/+)) [37+/-5 vs. 20+/-6.5 microg Ca/mg tissue, respectively, at 30 days (P<.001), and 42+/-5 versus 20+/-4 microg Ca/mg tissue at 60 days, respectively (P<.001)]. On the other hand, OPN levels within and surrounding the implants were similar in CAR2(+/+) and CAR2(-/-) mice, suggesting that OPN expression in the absence of CAR2 was not sufficient to mitigate ectopic calcification. CONCLUSIONS: These results indicate that CAR2 expression is an important regulator of ectopic calcification, potentially by facilitating OPN mediated mineral regression.


Asunto(s)
Calcinosis/enzimología , Anhidrasa Carbónica II/fisiología , Pericardio/metabolismo , Animales , Calcinosis/patología , Calcio/metabolismo , Bovinos , Fijadores/química , Glutaral/química , Ratones , Ratones Noqueados , Osteopontina/metabolismo , Pericardio/patología , Pericardio/trasplante , Fijación del Tejido
6.
J Mater Sci Mater Med ; 19(10): 3279-85, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18483788

RESUMEN

The phosphorylated glycoprotein osteopontin (OPN) is involved in the regulation of biomineralization under normal and pathological conditions. Its actions include inhibiting apatite crystal growth and promoting the formation and function of mineral resorbing cells, including osteoclasts (OCL). The purpose of this study was to develop stable apatitic mineral surfaces and determine their influence on OCL formation and mineral resorption from bone marrow macrophages derived from OPN wild-type (OPN+/+) and OPN deficient (OPN-/-) mice. We demonstrated that these mineral coatings were stable and supported bone marrow-derived macrophage differentiation to OCL under our culture conditions. Macrophages harvested from OPN-/- mice had a greater capacity to form OCL than macrophages from OPN+/+ mice when allowed to differentiate on tissue culture plastic. In contrast, when allowed to differentiate on a mineral surface, no difference in OCL formation was observed. Interestingly, OPN+/+ OCL were more efficient at mineral dissolution than OPN-/- OCL, and this difference was observed regardless of differentiating surface. Our results suggest that mineralized substrates as well as ability to synthesize OPN both control OCL function in our model system. The exact nature of these effects may be dependent on variables related to mineral substrate presentation.


Asunto(s)
Células de la Médula Ósea/fisiología , Calcificación Fisiológica/fisiología , Fosfatos de Calcio/metabolismo , Materiales Biocompatibles Revestidos/metabolismo , Osteoclastos/fisiología , Osteogénesis/fisiología , Osteopontina/fisiología , Animales , Células de la Médula Ósea/efectos de los fármacos , Células de la Médula Ósea/ultraestructura , Fosfatos de Calcio/farmacología , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Células Cultivadas , Materiales Biocompatibles Revestidos/farmacología , Genotipo , Macrófagos/efectos de los fármacos , Macrófagos/fisiología , Macrófagos/ultraestructura , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Electrónica de Rastreo , Osteoclastos/efectos de los fármacos , Osteoclastos/ultraestructura , Osteogénesis/genética , Osteopontina/deficiencia , Osteopontina/genética , Osteopontina/ultraestructura , Poliestirenos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA